FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200042147> ?p ?o ?g. }

• W3200042147 abstract "Membrane-associated RING-CH8 (MARCH8) impairs the cell surface expression of envelope glycoproteins from different viruses, reducing their incorporation into virions. Using stable cell lines with inducible MARCH8 expression, we show that MARCH8 did not alter susceptibility to influenza A virus (IAV) infection, but virions released from infected cells were markedly less infectious. Knockdown of endogenous MARCH8 confirmed its effect on IAV infectivity. The expression of MARCH8 impaired the infectivity of both H3N2 and H1N1 strains and was dependent on its E3 ligase activity. Although virions released in the presence of MARCH8 expressed smaller amounts of viral hemagglutinin (HA) and neuraminidase (NA) proteins, there was no impact on levels of the viral HA, NA, or matrix 2 (M2) proteins detected on the surface of infected cells. Moreover, mutation of lysine residues in the cytoplasmic tails of HA, NA, and/or M2, or in the viral M1 protein, did not abrogate MARCH8-mediated restriction. While MARCH1 and -8 target similar immunological ligands and both restrict HIV-1, only MARCH8 inhibited IAV infectivity. Deletion of the N-terminal cytoplasmic (N-CT) domain of MARCH8 confirmed it to be a critical determinant of IAV inhibition. Of interest, deletion of the MARCH1 N-CT or its replacement with the MARCH8 N-CT resulted in acquisition of IAV restriction. Together, these data demonstrate that MARCH8 restricts a late stage in IAV replication by a mechanism distinct to its reported activity against other viruses. Moreover, we show that the N-CT of MARCH8 is essential for anti-IAV activity, whereas the MARCH1 N-CT inhibits its ability to restrict IAV. IMPORTANCE The antiviral activity of MARCH8 has been associated with the downregulation of envelope glycoproteins from a range of different viruses, resulting in reduced incorporation into nascent virions. Here, we show that MARCH8 restricts IAV at a late stage in virus replication, but this was not associated with reduced expression of IAV envelope glycoproteins on the surface of infected cells, pointing to a distinct mechanism of antiviral activity. Our studies also demonstrate the differential ability of MARCH1 and -8 to restrict IAV infectivity, highlighting the critical role of the N-CT domain of each protein in modulating IAV restriction. Overall, these studies provide novel insights regarding the mechanisms by which MARCH proteins contribute to cell-intrinsic immunity against IAV." @default.
• W3200042147 created "2021-09-27" @default.
• W3200042147 creator A5034884147 @default.
• W3200042147 creator A5046372376 @default.
• W3200042147 creator A5055857904 @default.
• W3200042147 creator A5069450540 @default.
• W3200042147 date "2021-10-26" @default.
• W3200042147 modified "2023-09-29" @default.
• W3200042147 title "MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells" @default.
• W3200042147 cites W1545285195 @default.
• W3200042147 cites W1931451499 @default.
• W3200042147 cites W1985658715 @default.
• W3200042147 cites W1987716416 @default.
• W3200042147 cites W1988024135 @default.
• W3200042147 cites W1989466170 @default.
• W3200042147 cites W1990151313 @default.
• W3200042147 cites W2004313038 @default.
• W3200042147 cites W2010531443 @default.
• W3200042147 cites W2012394593 @default.
• W3200042147 cites W2030588393 @default.
• W3200042147 cites W2033352476 @default.
• W3200042147 cites W2057700014 @default.
• W3200042147 cites W2058209707 @default.
• W3200042147 cites W2060736883 @default.
• W3200042147 cites W2069624186 @default.
• W3200042147 cites W2094741369 @default.
• W3200042147 cites W2104156478 @default.
• W3200042147 cites W2114941904 @default.
• W3200042147 cites W2122947838 @default.
• W3200042147 cites W2142061382 @default.
• W3200042147 cites W2148192361 @default.
• W3200042147 cites W2149368193 @default.
• W3200042147 cites W2149616074 @default.
• W3200042147 cites W2151532924 @default.
• W3200042147 cites W2163510440 @default.
• W3200042147 cites W2167663744 @default.
• W3200042147 cites W2464603766 @default.
• W3200042147 cites W2528241483 @default.
• W3200042147 cites W2565732701 @default.
• W3200042147 cites W2599415479 @default.
• W3200042147 cites W2606220583 @default.
• W3200042147 cites W2909188254 @default.
• W3200042147 cites W2914880096 @default.
• W3200042147 cites W2951121820 @default.
• W3200042147 cites W3004362226 @default.
• W3200042147 cites W3048519524 @default.
• W3200042147 cites W3085027872 @default.
• W3200042147 cites W3135184154 @default.
• W3200042147 cites W3135981224 @default.
• W3200042147 cites W3183546851 @default.
• W3200042147 doi "https://doi.org/10.1128/mbio.01484-21" @default.
• W3200042147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8546552" @default.
• W3200042147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34517760" @default.
• W3200042147 hasPublicationYear "2021" @default.
• W3200042147 type Work @default.
• W3200042147 sameAs 3200042147 @default.
• W3200042147 citedByCount "8" @default.
• W3200042147 countsByYear W32000421472022 @default.
• W3200042147 countsByYear W32000421472023 @default.
• W3200042147 crossrefType "journal-article" @default.
• W3200042147 hasAuthorship W3200042147A5034884147 @default.
• W3200042147 hasAuthorship W3200042147A5046372376 @default.
• W3200042147 hasAuthorship W3200042147A5055857904 @default.
• W3200042147 hasAuthorship W3200042147A5069450540 @default.
• W3200042147 hasBestOaLocation W32000421473 @default.
• W3200042147 hasConcept C106358424 @default.
• W3200042147 hasConcept C108625454 @default.
• W3200042147 hasConcept C134164806 @default.
• W3200042147 hasConcept C140704245 @default.
• W3200042147 hasConcept C153911025 @default.
• W3200042147 hasConcept C159047783 @default.
• W3200042147 hasConcept C173396325 @default.
• W3200042147 hasConcept C185592680 @default.
• W3200042147 hasConcept C2522874641 @default.
• W3200042147 hasConcept C2777546802 @default.
• W3200042147 hasConcept C54355233 @default.
• W3200042147 hasConcept C58475186 @default.
• W3200042147 hasConcept C68434959 @default.
• W3200042147 hasConcept C81885089 @default.
• W3200042147 hasConcept C86803240 @default.
• W3200042147 hasConceptScore W3200042147C106358424 @default.
• W3200042147 hasConceptScore W3200042147C108625454 @default.
• W3200042147 hasConceptScore W3200042147C134164806 @default.
• W3200042147 hasConceptScore W3200042147C140704245 @default.
• W3200042147 hasConceptScore W3200042147C153911025 @default.
• W3200042147 hasConceptScore W3200042147C159047783 @default.
• W3200042147 hasConceptScore W3200042147C173396325 @default.
• W3200042147 hasConceptScore W3200042147C185592680 @default.
• W3200042147 hasConceptScore W3200042147C2522874641 @default.
• W3200042147 hasConceptScore W3200042147C2777546802 @default.
• W3200042147 hasConceptScore W3200042147C54355233 @default.
• W3200042147 hasConceptScore W3200042147C58475186 @default.
• W3200042147 hasConceptScore W3200042147C68434959 @default.
• W3200042147 hasConceptScore W3200042147C81885089 @default.
• W3200042147 hasConceptScore W3200042147C86803240 @default.
• W3200042147 hasFunder F4320334705 @default.
• W3200042147 hasIssue "5" @default.
• W3200042147 hasLocation W32000421471 @default.
• W3200042147 hasLocation W32000421472 @default.
• W3200042147 hasLocation W32000421473 @default.

• next